Skip to main content
Equibles
BCYC logo

BCYC · Bicycle Therapeutics PLC · Metrics

Track BCYC — free

Use BCYC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research BCYC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.67 +0.05 (+1.38%)
Rebalance outlook locked
Market Cap
$253.74M
Shares
70.09M
Volume · Nov 3 81.49K Avg daily vol (3M) 409.69K

BCYC metrics

81 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.67
Market cap
$253.74M

Price action

20 metrics
Price change (1W)
-0.8%
Price change (30D)
-9.7%
Price change (3M)
-6.5%
Price change (6M)
-26.7%
Price change (YTD)
-48.9%
Price change (1Y)
-55.1%
Trailing year
Price change (5Y)
-93.4%
52-week high
$7.52
52-week low
$3.38
Change from 52-week high
-51.9%
Change from 52-week low
+7.1%
Annualized volatility
51.6%
Annualized volatility (3M)
56.2%
Beta
1.6
RSI (14D)
46.7
Price vs SMA 50
-5.2%
Price vs SMA 200
-20.4%
Avg volume (3M)
413,669
Relative volume
0.8
Average dollar volume
$1.58M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
70.09M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.0×
reciprocal yield 32.9%
P / book
0.5
reciprocal yield 199.1%
FCF yield
-69.8%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-55.9%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
23.2×
reciprocal yield 4.3%
EV / revenue historical average (5Y)
27.9×
reciprocal yield 3.6%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-10-30

Profitability

9 metrics
Gross margin
—
Operating margin
-189.4%
Trailing 12 months
Net margin
-169.8%
Gross profit (TTM)
—
Operating profit (TTM)
−$158.23M
Net income (TTM)
−$141.79M
Trailing 12 months
Diluted EPS (TTM)
$-2.03
FCF margin
-211.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$1.20
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-2.27
EBITDA per diluted share (TTM)
$-2.20
Net income per diluted share (TTM)
$-2.03
Operating cash flow per diluted share (TTM)
$-2.51
Free cash flow per diluted share (TTM)
$-2.54
Capital expenditures per diluted share (TTM)
$0.03
R&D per diluted share (TTM)
$2.52
Stock compensation per diluted share (TTM)
$0.44
Book value per share
$7.22

Growth

11 metrics
Revenue growth YoY
+190.2%
Year over year
Net income growth YoY
—
Revenue (TTM)
$83.53M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.0%
Year over year · more shares
Revenue CAGR (3Y)
+71.2%
Revenue CAGR (5Y)
+47.5%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-28.1%
Return on assets
-25.0%
Debt / equity
—
Current ratio
12.1
EBITDA (TTM)
−$153.61M
Free cash flow (TTM)
−$177.04M
Quick ratio
12.1
Interest coverage
-815.6
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$469.93M
Total assets
$567.18M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$175.18M
Capital expenditures (TTM)
$1.86M
R&D (TTM)
$175.25M
SG&A (TTM)
—
Stock compensation (TTM)
$30.41M
R&D / revenue
209.8%
Stock compensation / revenue
36.4%

Ownership (13F)

9 metrics
13F filers
103
13F filer change QoQ
+5
Institutional ownership
53.8%
Conviction holders (share of 13F filers)
1.0%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
-0.7%
Holder tenure
10.8
Price vs estimated holder cost
-72.3%

Ownership (registered funds)

1 metrics
Index-fund ownership
0.6%

Short interest

3 metrics
Short interest
4.9%
Latest settlement · 6.2 days to cover
Days to cover
6.2d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$58,726
Insider-sentiment score
31 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1761612 CUSIP 088786108 13F (30d) 14 filings 14 filers Visit website Investor relations